Chief Business Officer
Micah joined Locana in April, 2020 as Chief Business Officer. He joins us from Assembly Biosciences where he served as Senior Vice President, Corporate Development and Strategy leading business development efforts since 2015. Prior to Assembly, he was Senior Director, Corporate Investment at Jabil Healthcare & Life Sciences where he led healthcare transactions. Previously, Micah served as Head of Corporate Strategy and Senior Director, New Ventures at H. Lundbeck A/S focused on neuroscience. Prior to the acquisition by Lundbeck, he was Director, Corporate Development and M&A at Ovation Pharmaceuticals, a rare disease, neuroscience company that launched the first product for Huntington’s Disease. Micah previously held financial roles at Eli Lilly and Pfizer. Micah earned a Bachelor of Science degree in Finance from Indiana University.